Validation of determination of human α-amylase activity for patients with pancreatic diseas

Blood α-amylase activity is a key laboratory marker of pancreatic diseases. At the same time, some of the common laboratory methods of its measurement have a number of limitations. Therefore new more effective laboratory methods are currently being developed over those methods that have been already...

Full description

Bibliographic Details
Main Authors: K. A. Cheremisina, E. G. Yakovleva, A. V. Baraboshkina, E. F. Agletdinov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2021-08-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/640
_version_ 1797269548138758144
author K. A. Cheremisina
E. G. Yakovleva
A. V. Baraboshkina
E. F. Agletdinov
author_facet K. A. Cheremisina
E. G. Yakovleva
A. V. Baraboshkina
E. F. Agletdinov
author_sort K. A. Cheremisina
collection DOAJ
description Blood α-amylase activity is a key laboratory marker of pancreatic diseases. At the same time, some of the common laboratory methods of its measurement have a number of limitations. Therefore new more effective laboratory methods are currently being developed over those methods that have been already available. The aim of this work was to compare two methods of determination of the activity of total and pancreatic α-amylase in human blood based on using 4,6-ethylidene-(G7)-p-nitrophenyl-(G1)-α,D-maltoheptaoside (EPS-G7) and 2-chloro-4-nitrophenyl-4-O-β-D-galactopyranosylmaltoside (GalG2CNP) as substrates. Blood serum samples from patients with different levels of α-amylase activity were analyzed. The main analytical characteristics of the method with the GalG2CNP substrate were determined using purified α-amylase specimens. A high-sized correlation and high accuracy of the α-amylase isoenzymes activity were observed for the both methods. Therefore, the method for determining the activity of α-amylase using GalG2CNP as a substrate has analytical characteristics similar to the common laboratory method with EPS-G7, but at the same time, the existing advantages allow it to be recommended for wider application in clinical laboratory diagnostics and scientific research.
first_indexed 2024-03-08T14:34:16Z
format Article
id doaj.art-aef15daf652549528b576db695b09260
institution Directory Open Access Journal
issn 2410-2512
2410-2520
language Russian
last_indexed 2024-04-25T01:50:07Z
publishDate 2021-08-01
publisher Russian Academy of Sciences, Siberian Branch Publishing House
record_format Article
series Сибирский научный медицинский журнал
spelling doaj.art-aef15daf652549528b576db695b092602024-03-07T18:49:59ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202021-08-01414798510.18699/SSMJ20210411371Validation of determination of human α-amylase activity for patients with pancreatic diseasK. A. Cheremisina0E. G. Yakovleva1A. V. Baraboshkina2E. F. Agletdinov3JSC Vector-BestJSC Vector-BestJSC Vector-BestJSC Vector-BestBlood α-amylase activity is a key laboratory marker of pancreatic diseases. At the same time, some of the common laboratory methods of its measurement have a number of limitations. Therefore new more effective laboratory methods are currently being developed over those methods that have been already available. The aim of this work was to compare two methods of determination of the activity of total and pancreatic α-amylase in human blood based on using 4,6-ethylidene-(G7)-p-nitrophenyl-(G1)-α,D-maltoheptaoside (EPS-G7) and 2-chloro-4-nitrophenyl-4-O-β-D-galactopyranosylmaltoside (GalG2CNP) as substrates. Blood serum samples from patients with different levels of α-amylase activity were analyzed. The main analytical characteristics of the method with the GalG2CNP substrate were determined using purified α-amylase specimens. A high-sized correlation and high accuracy of the α-amylase isoenzymes activity were observed for the both methods. Therefore, the method for determining the activity of α-amylase using GalG2CNP as a substrate has analytical characteristics similar to the common laboratory method with EPS-G7, but at the same time, the existing advantages allow it to be recommended for wider application in clinical laboratory diagnostics and scientific research.https://sibmed.elpub.ru/jour/article/view/640pancreatitislaboratory diagnosticsα-amylaseactivityisoenzymesubstrate
spellingShingle K. A. Cheremisina
E. G. Yakovleva
A. V. Baraboshkina
E. F. Agletdinov
Validation of determination of human α-amylase activity for patients with pancreatic diseas
Сибирский научный медицинский журнал
pancreatitis
laboratory diagnostics
α-amylase
activity
isoenzyme
substrate
title Validation of determination of human α-amylase activity for patients with pancreatic diseas
title_full Validation of determination of human α-amylase activity for patients with pancreatic diseas
title_fullStr Validation of determination of human α-amylase activity for patients with pancreatic diseas
title_full_unstemmed Validation of determination of human α-amylase activity for patients with pancreatic diseas
title_short Validation of determination of human α-amylase activity for patients with pancreatic diseas
title_sort validation of determination of human α amylase activity for patients with pancreatic diseas
topic pancreatitis
laboratory diagnostics
α-amylase
activity
isoenzyme
substrate
url https://sibmed.elpub.ru/jour/article/view/640
work_keys_str_mv AT kacheremisina validationofdeterminationofhumanaamylaseactivityforpatientswithpancreaticdiseas
AT egyakovleva validationofdeterminationofhumanaamylaseactivityforpatientswithpancreaticdiseas
AT avbaraboshkina validationofdeterminationofhumanaamylaseactivityforpatientswithpancreaticdiseas
AT efagletdinov validationofdeterminationofhumanaamylaseactivityforpatientswithpancreaticdiseas